Spain’s Sleep Aid Industry Reflects Changing Consumer Preferences and Growing Focus on Sleep Health

The Spain sleep aids market is valued at USD 245 million in 2025 and is projected to reach USD 270 million by 2032, reflecting a CAGR of 1.4%.

rahul Sharmarahul SharmaAuthor13 November 20265 min read 26 views
Spain’s Sleep Aid Industry Reflects Changing Consumer Preferences and Growing Focus on Sleep Health
In this article▾
  1. Growing Awareness of Sleep Disorders Supports Product Demand
  2. Melatonin Maintains a Leading Position Among Product Categories
  3. Gummies and Sprays Introduce New Product Formats
  4. Retail Pharmacies Remain the Primary Distribution Channel
  5. Age-Specific Products Create Opportunities for Differentiation
  6. Competition Includes Established Pharmaceutical and Consumer Health Companies
  7. Outlook: Product Differentiation and Healthcare Awareness Shape Development

Sleep quality has become an increasingly important aspect of personal health and wellbeing in Spain. Growing awareness of sleep disorders, changing lifestyles and interest in accessible sleep-support products are influencing consumer preferences. The availability of different formulations, including tablets, gummies, capsules and sprays, is also creating a more diversified product landscape. Consumers are increasingly encountering products positioned around convenience, ingredient preferences and specific sleep-related needs.

According to Vyansa Intelligence, Spain’s sleep aids industry was valued at USD 245 million in 2025 and is projected to reach USD 270 million by 2032, registering a compound annual growth rate (CAGR) of 1.4% between 2026 and 2032. The relatively moderate growth outlook reflects an established product category in which consumer awareness, product differentiation and changing purchasing preferences influence industry development.

Growing Awareness of Sleep Disorders Supports Product Demand

Sleep disorders remain an important health consideration in Spain, with insomnia receiving increasing attention from healthcare professionals and the wider public. Greater awareness of sleep quality and its relationship with everyday functioning has encouraged more consumers to recognise persistent sleep difficulties as a health concern rather than simply a temporary inconvenience.

The Spanish Ministry of Health's Annual Report on the National Health System 2023 identifies sleep disorders among the commonly recorded mental health and behavioural conditions. Its data also indicates an increase in recorded insomnia prevalence between 2016 and 2022. This growing clinical recognition provides important context for the continued relevance of sleep-support products and healthcare interventions.

However, consumer purchasing does not always correspond with formal diagnosis or structured treatment. The Vyansa Intelligence study identifies underdiagnosis as a challenge, as individuals experiencing sleep disturbances may purchase products independently rather than follow consistent healthcare-guided treatment pathways. This creates a varied purchasing environment involving pharmaceutical, melatonin-based and herbal sleep-support options.

Melatonin Maintains a Leading Position Among Product Categories

Melatonin accounted for approximately 40% of Spain's sleep aids industry by product type in 2025, according to Vyansa Intelligence. Its position reflects consumer familiarity with the ingredient and its association with the body's natural sleep-wake cycle. Melatonin-based products are available in different formulations, allowing manufacturers to address preferences for conventional tablets and newer delivery formats.

Single-ingredient products include doxylamine succinate, diphenhydramine and melatonin. Combination formulations represent another category, including diphenhydramine combined with acetaminophen and other antihistamine-based combinations. Herbal and traditional sleep aids also contribute to product diversity, with ingredients such as valerian root, passionflower, chamomile and multi-herbal blends.

These categories serve different consumer preferences and product requirements. The availability of pharmaceutical ingredients alongside herbal formulations illustrates how the industry accommodates different approaches to sleep support. Nevertheless, the suitability of individual products depends on their ingredients, intended use and relevant medical guidance.

Gummies and Sprays Introduce New Product Formats

Product formulation is becoming an important area of differentiation in Spain. Traditional tablets continue to have a place in the category, while manufacturers are also introducing gummies, sprays, capsules, liquids and sublingual products. These alternatives provide different consumption experiences and appeal to consumers seeking convenient formats.

The Vyansa Intelligence study identifies gummies and sprays as emerging product formats. Their development reflects interest in portability, ease of administration and alternative delivery methods. The introduction of melatonin-based sprays and anti-stress sprays in 2023 illustrates the diversification taking place beyond conventional tablet products.

Herbal ingredients are also influencing formulation development. Combinations involving chamomile, lavender and vitamin B6 are being incorporated into products positioned around relaxation and sleep support. These developments provide manufacturers with opportunities to differentiate products through ingredient combinations and presentation, although product claims still require appropriate scientific and regulatory support.

Retail Pharmacies Remain the Primary Distribution Channel

Retail offline channels accounted for approximately 75% of Spain's sleep aids distribution in 2025, making them the leading sales channel. Pharmacies play an important role because consumers can access products directly and seek information from pharmacists when comparing available options.

The importance of physical retail is particularly relevant in a healthcare-related product category where consumers may have questions about ingredients, usage and suitability. Pharmacist interaction can provide additional reassurance, especially for individuals considering different formulations or products for the first time.

Online retail represents another distribution channel, offering consumers opportunities to compare products, brands and formulations. Digital platforms also allow manufacturers and retailers to communicate product information and maintain visibility across different consumer groups. Nevertheless, the continued dominance of offline distribution highlights the relevance of established pharmacy networks in Spain's sleep-support product landscape.

Age-Specific Products Create Opportunities for Differentiation

Demographic preferences are becoming increasingly relevant to product development. Different age groups can experience different sleep-related concerns, creating opportunities for manufacturers to develop products with clearly defined intended users and formulations.

The Vyansa Intelligence study identifies young to mid-adults aged 25–44, middle-aged adults aged 45–64 and the geriatric population aged 65 and above as important consumer categories. Older adults represent a relevant demographic group for specialised sleep-support products, while working-age consumers provide another audience for products positioned around lifestyle-related sleep difficulties.

The growing focus on demographic segmentation may encourage manufacturers to develop more specific product portfolios. However, age-specific formulations require careful consideration of safety, dosage and medical suitability. Clear labelling and appropriate professional guidance remain important when addressing the needs of different consumer groups.

Competition Includes Established Pharmaceutical and Consumer Health Companies

Spain's sleep aids industry includes pharmaceutical manufacturers, consumer healthcare businesses and companies offering herbal and traditional formulations. Companies identified in the Vyansa Intelligence study include Laboratorios Normon SA, Chiesi España SA, Vemedia Pharma Iberia SA, Esteve SA, Uriach-Aquilea OTC SL and Procter & Gamble España SA.

Other companies covered include Laboratorios URGO SL, Cinfa SA Laboratorios, Angelini Farmaceutica SA and Laboratorios Hartmann SA.

Competition is influenced by product formulation, brand recognition, distribution reach and consumer confidence. Established pharmaceutical companies operate alongside businesses focusing on natural ingredients and alternative delivery formats. This creates a competitive environment in which manufacturers differentiate themselves through product portfolios, ingredient combinations and retail availability.

Outlook: Product Differentiation and Healthcare Awareness Shape Development

Spain's sleep aids industry is projected to increase from USD 245 million in 2025 to USD 270 million by 2032, according to Vyansa Intelligence. The forecast indicates gradual expansion, with continued awareness of sleep disorders and changing consumer preferences supporting the industry's development.

The future competitive environment will depend partly on how manufacturers respond to demand for convenient formulations, ingredient transparency and products addressing different demographic requirements. Melatonin's established position, the introduction of gummies and sprays, and the continued importance of pharmacy distribution highlight the different factors influencing the category. Healthcare awareness, responsible product positioning and appropriate consumer guidance will remain relevant to the industry's development through 2032.

Keep reading

More from rahul Sharma

More in healthcare

More in healthcare

Have a story of your own?

Publisha is free to start. Write with AI that keeps your voice, and publish in a click.